State Of Alaska, Department Of Revenue Vertex Pharmaceuticals Inc Transaction History
State Of Alaska, Department Of Revenue
- $9.35 Billion
- Q2 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 45,255 shares of VRTX stock, worth $17 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
45,255
Previous 46,505
2.69%
Holding current value
$17 Million
Previous $22.5 Million
10.64%
% of portfolio
0.22%
Previous 0.26%
Shares
32 transactions
Others Institutions Holding VRTX
# of Institutions
1,828Shares Held
232MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$10.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$8.81 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$7.99 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$5.45 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.42 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $96.3B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...